Accelerating Cell Line Development From Transfection to Manufacturing

Generating a highly expressing, regulatory compliant clonal cell line is key when developing a biopharmaceutical. Yet cell line development is labor-intensive, time consuming and costly.

The production of a high-quality and productive cell line requires both an expression system that yields high expressing clones and a workflow that allows selection of the highest producing clones.

In this webinar, you’ll discover how combining a single-cell analysis platform with a novel glutamine synthetase-Chinese hamster ovary expression system can yield highly productive, scalable, clonal cell lines for developing biopharmaceuticals.

Attend this webinar to:

• Hear about the workflow and techniques required to build a panel of scalable clones
• Learn about picodroplets and their advantages for cell line development
• Discover how real-world researchers drastically reduced their workflow timeline and costs
• Learn how automation can enable you to achieve regulatory accepted cells without compromising on monoclonality, traceability, productivity or scalability